Proscan Tablet

Prostate cancer

Oral Palliative treatment of prostatic carcinoma Adult: 250 mg tid preferably at least 3 days before gonadorelin analogue treatment.

May be taken with or without food.

Hypersensitivity, severe hepatic impairment, pregnancy and lactation.

Perform liver function tests before starting treatment and at regular intervals. Treatment is not recommended in patients whose ALT values exceed twice the upper limit of normal. Regular assessment of prostate specific antigen level may help to monitor disease progression. Advise patient against discontinuing drug on their own. Exercise caution in patients with cardiac disease. Lactation: Excretion in milk unknown; not recommended

D Pregnancy Category: D Lactation: Excretion in milk unknown; not recommended

Increased prothrombin time in patients on long-term warfarin treatment.

>10% Hot flashes (61%),Decreased libido (36%),Impotence (31%),Diarrhea (12%),Nausea/vomiting (11%) 1-10% Gynecomastia (9%),Anorexia (4%),Edema (4%),Leukopenia (3%),Rash (3%) Frequency Not Defined Hemolytic anemia, methemoglobinemia Increased AST, ALT, bilirubin, BUN

Flutamide is a nonsteroidal 'pure' antiandrogen which acts directly on the target tissues either by blocking androgen uptake or by inhibiting cytoplasmic and nuclear binding of androgen.

Proscan 250mg Tablet manufactured by Renata PLC.. Its generic name is Flutamide.